0001566028-13-000018.txt : 20131001
0001566028-13-000018.hdr.sgml : 20131001
20131001124217
ACCESSION NUMBER: 0001566028-13-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130927
FILED AS OF DATE: 20131001
DATE AS OF CHANGE: 20131001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC
CENTRAL INDEX KEY: 0000887497
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 112638720
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 369 BAYVIEW AVENUE
CITY: AMITYVILLE
STATE: NY
ZIP: 11701
BUSINESS PHONE: 5167898228
MAIL ADDRESS:
STREET 1: 369 BAYVIEW AVE.
CITY: AMITYVILLE
STATE: NY
ZIP: 11701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDWYN MARTIN M
CENTRAL INDEX KEY: 0001186837
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20424
FILM NUMBER: 131126092
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-09-27
0000887497
HI TECH PHARMACAL CO INC
HITK
0001186837
GOLDWYN MARTIN M
C/O TASHLIK KREUTZER GOLDWYN & CRANDELL
40 CUTTERMILL ROAD
GREAT NECK
NY
11021
1
0
0
0
Common Stock
2013-09-27
4
M
0
4308
13.50
A
4308
D
Common Stock
2013-09-27
4
J
0
4308
0
D
0
D
Common Stock
2013-09-27
4
M
0
3000
24.95
A
3000
D
Common Stock
2013-09-27
4
S
0
3000
43.10
D
0
D
Common Stock
2013-09-30
4
M
0
3111
13.50
A
3111
D
Common Stock
2013-09-30
4
J
0
3111
0
D
0
D
Stock Option (Right to Buy)
13.50
2013-09-27
4
M
0
4308
0
D
2004-11-28
2013-11-28
Common Stock
4308
3111
D
Stock Option (Right to Buy)
24.95
2013-09-27
4
M
0
3000
0
D
2006-11-08
2015-11-08
Common Stock
3000
9375
D
Stock Option (Right to Buy)
13.50
2013-09-30
4
M
0
3111
0
D
2004-11-28
2013-11-28
Common Stock
3111
0
D
The shares acquired upon exercise of the options reflected on this form were immediately distributed without consideration to a partner or partners in Mr. Goldwyn's law firm.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.07 to $43.15, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) of this Form 4.
Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
The option became exercisable in four equal annual installments beginning on the first anniversary of the grant date.
Other than the option to acquire an additional 9,375 shares of the Company's stock reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 75,400 shares of the Company's stock (for options to acquire an aggregate of 84,775 shares). The other options were granted on various dates, with varying exercise prices and exercisable and expiration dates.
Martin M. Goldwyn
2013-10-01